Press release
Global Psoriasis Drugs Market Growth, Size, Share, Industry Report and Forecast 2019-2025
The global psoriasis drug market is expected to grow at a significant CAGR during the forecast period. The market is segmented on the basis of drug class and route of administration. Based on the drug class, the market is segmented into TNF inhibitors, interleukin inhibitors, vitamin D analogs, and others. Based on the route of administration, the market is segmented into oral, parenteral, and topical.To Request a Sample of our Report on Global Psoriasis Drugs Market: https://www.omrglobal.com/request-sample/psoriasis-drugs-market
There is an array of topical and systemic drug therapies that are optimized in such a way to gain optimal benefit and compliance. Treatment for each patient is customized in such a way to reduce adverse effects, based on the patient’s drug history, existing quality of life, caregiver situation, self-care capability, financial needs and feasibility for the treatment. Initially, the treatment is usually started with economical therapies and then intensified to newer and advanced ones until an acceptable and effective therapy is reached with good compliance. Some of the most common drugs preferred for the treatment include corticosteroids and vitamin D analogs.
Corticosteroids are the most commonly prescribed medications for treating mild to moderate psoriasis. It aids in slowing down the cell turnover by suppressing the immune system, which reduces inflammation and itching. Low-potency corticosteroid ointments are usually recommended for sensitive areas such as the face or skin folds, and for treating widespread patches of damaged skin. Adverse effects seen are thinning of the skin, telangiectasia, and systemic side effects such as diabetes, hypertension, and HPA suppression. Some of the corticosteroids used are clobetasol propionate 0.05%, amcinonide 0.1%, betamethasone dipropionate, betamethasone valerate as 0.1%, 0.12% and 1%, halcinonide 0.1%, Desoximetasone 0.25% and mometasone furoate.
Vitamin D Analogues – Vitamin D analogs (calcitriol and calcipotriene) have emerged as important alternatives to topical corticosteroids for the long-term therapy of psoriasis. They bind to cytoplasmic Vitamin D Receptor then translocate into the nucleus, where they bind to the nuclear receptor and commence the transcription of vitamin D responsive genes. These transcription proteins then regulate cell differentiation and downregulate cell proliferation and inflammatory processes associated with this condition. They are considered a safe alternative, despite causing perilesional irritation and erythema.
They may rarely increase serum and urine calcium levels, so the total concentration per week should not exceed 100 gm. Calcitriol is a more potent analog but calcipotriene is the most established one. Calcipotriene has shown to affect calcium homeostasis to a very lesser extent. Most trials have shown that combination treatment of vitamin D and a corticosteroid was usually more effective than monotherapy with either used alone.
Additionally, some other drug class that is utilized in the psoriasis treatment includes TNF Inhibitors, Interleukin Inhibitors, among others offered by the key players. The key players operating in the global psoriasis drugs market is also driving the market growth. Players such as AbbVie, Inc., Amgen Inc., Eli Lilly and Co., Johnson & Johnson Services Inc., Novartis International AG, AstraZeneca Plc, Boehringer Ingelheim International GmbH, Pfizer, Inc., and Sun Pharmaceutical Industries Ltd., are significantly contributing to the growth of the global psoriasis drugs industry by adopting various growth strategies.
Product launches & developments, partnerships, agreements, and acquisitions are among some of the strategies adopted by the players to sustain in a competitive Psoriasis Drugs market during the forecast period. For instance, in August 2019, Amgen Inc. announced to pay $13.4 billion for a blockbuster psoriasis drug from Celgene Corp., which is shedding the asset to win antitrust regulators’ sign-off for Celgene’s $74-billion merger with Bristol-Myers Squibb Co.
(Get 15% Discount on Buying this Report)
A full Report of Global Psoriasis Drugs Market is Available at: https://www.omrglobal.com/industry-reports/psoriasis-drugs-market
Global Psoriasis Drugs Market – Segmentation
By Drug Class
• TNF Inhibitors
• Interleukin Inhibitors
• Vitamin D Analogs
• Others
By Route of Administration
• Oral
• Parenteral
• Topical
Regional Analysis
North America
• United States
• Canada
Europe
• UK
• Germany
• Spain
• France
• Italy
• Rest of Europe
Asia-Pacific
• India
• China
• Japan
• Rest oF APAC
Rest of The World
Company Profiles
• AbbVie, Inc.
• Amgen Inc.
• AstraZeneca Plc
• Bausch Health Companies Inc.
• Biogen, Inc.
• Boehringer Ingelheim International GmbH
• Celltrion Healthcare Co. Ltd.
• Dr. Reddy's Laboratories Ltd.
• Eli Lilly and Co.
• Johnson & Johnson Services Inc.
• LEO Pharma A/S
• Merck & Co. Inc.
• Novartis International AG
• Pfizer, Inc.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Co. Ltd.
• UCB SA
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/psoriasis-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Psoriasis Drugs Market Growth, Size, Share, Industry Report and Forecast 2019-2025 here
News-ID: 2304446 • Views: …
More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…

Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…

Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033.
Property Management Service Market Overview
The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly…

5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033.
5G Chipset Market Overview
The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…